Another pro-survival factor that is upregulated in BlCa is Bcl-2, associated with BlCa clinical stages and lymph node involvement [179], which inhibited apoptosis induced by the chemotherapeutic cisplatin [180]. This evidence concerns the gene BCL2 and bladder transitional cell carcinoma.